Logo

Adverse events reporting | Prescribing information ( This product is under additional monitoring)

HCP support materials

line

Useful videos about TREMYFA® in PsA patients

What does Discover-2 mean for bio-naïve patients patients with PsA?

Prescribing information is available to all viewers of this video. Please click the prescribing information tab on this page or visit https://www.medicines.ie/

What does Cosmos mean for PsA patients who have failed on anti-tnf therapy?

Prescribing information is available to all viewers of this video. Please click the prescribing information tab on this page or visit https://www.medicines.ie/

line

PsA clinical publications

Efficacy and safety of Guselkumab, a monoclonal antibody specific to the 19-subunit of interleukin23, through 2 years: Results from a phase 3, randomised double blind, placebo controlled study conducted in biologic naïve patients with active psoriatic arthritis.

McInnes IB, Rahman P, Gottlieb AB, Hsia EC, Kollmeier AP, Chakravarty SD, et al. Efficacy and safety of guselkumab, an interleukin-23p19-specific monoclonal antibody, through 1 year in biologic-naive psoriatic arthritis patients. Arthritis Rheumatol 2021. Apr;73(4):604-616.

RMD Open Feb 2021, 7 (1) e001457; DOI: 10.1136/rmdopen-2020-001457
Guselkumab, an inhibitor of the IL- 23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic- naïve or TNFα inhibitor- experienced.

Ritchlin et al

Efficacy and safety of Guselkumab in patients with active psoriatic arthritis who demonstrated inadequate response to tumor necrosis factor inhibition: week 24 results of a phase 3B, randomized, controlled study.

line

Patient materials and resources

MyTremfya

MyTremfya is a support website for your patients who have been prescribed Tremfya for Psoriatic arthritis. MyTremfya provides important information to support and guide your patients on their treatment journey.

Patient Advice Booklet

The Patient Advice Booklet is an important resource for patients, containing information about Tremfya®, what it is, what you need to know before you start treatment, how to store and use your medication and what side effects can potentially occur.

Beyond Expectations

Help your patients understand what living with psoriatic disease means. 

The Beyond Expectations website provides your patients with lots of helpful advice and information about their condition.

Adverse events should be reported. This medicinal product is subject to additional monitoring and it is therefore important to report any suspected adverse events related to this medicinal product. Healthcare professionals are asked to report any suspected adverse events via: HPRA Pharmacovigilance Website: www.hpra.ie. Adverse events should also be reported to Janssen Sciences Ireland UC on 1800 709 122 or at dsafety@its.jnj.com.
CP-243578 - February 2022